As of 2026-03-23, the Relative Valuation of Gritstone Oncology Inc (GRTS) is (60.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.03 USD, the upside of Gritstone Oncology Inc based on Relative Valuation is -188217.8%.
The range of the Relative Valuation is (58.02) - (67.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.1x - 27.2x | 24.3x |
| Forward P/E multiples | 21.0x - 25.6x | 21.8x |
| Fair Price | (58.02) - (67.38) | (60.57) |
| Upside | -180301.3% - -209355.5% | -188217.8% |
| Date | P/E |